ListarProducción científica por tema "Factores de riesgo"
Mostrando ítems 1-6 de 6
-
Cohort Profile: The 10/66 study
(International Journal of Epidemiology, 2017) -
Population normative data for the 10/66 Dementia Research Group cognitive test battery from Latin America, India and China: a cross-sectional survey.
(BMC Neurology, 2009)1) To report site-specific normative values by age, sex and educational level for four components of the 10/66 Dementia Research Group cognitive test battery; 2) to estimate the main and interactive effects of age, sex, ... -
The prevalence and social patterning of chronic diseases among older people in a population undergoing health transition: a 10/66 group cross-sectional population-based survey in the Dominican Republic .
(BMC Public Health, 2010)Very little of the increased attention towards chronic diseases in countries with low and middle incomes has been directed towards older people, who contribute 72% of all deaths, and 14% of all Disability Adjusted Life Years ... -
Prevalence of parkinsonism and Parkinson disease in urban and rural populations from Latin America: A community based study
(The Lancet Regional Health - Americas 2022;7: 100136, 2021-12-10)Age and gender specific prevalence rates for parkinsonism and Parkinson’s disease (PD) are important to guide research, clinical practice, and public health planning; however, prevalence estimates in Latin America (LatAm) ... -
The prevalence, correlates and impact of anaemia among older people in Cuba, Dominican Republic, Mexico, Puerto Rico and Venezuela.
(British Journal of Haematology, 2013)Anaemia among older people is increasingly recognized as a matter of public health concern. Data from low- and middleincome countries are sparse. We surveyed 10915 people aged 65 years and over (8423 with blood tests) in ... -
Reproductive period, endogenous estrogen exposure and dementia incidence among women in Latin America and China: a 10/66 population-based cohort study.
(PloS Medicine, 2018)Exposure to endogenous estrogen may protect against dementia, but evidence remains equivocal. Such effects may be assessed more precisely in settings where exogenous estrogen administration is rare. We aimed to ...